- Home
- ISOU vs EBS Comparison
ISOU vs EBS Comparison
Compare ISOU & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISOU | EBS |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.4M | 434.4M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ISOU | EBS |
|---|---|---|
| Price | $10.01 | $8.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 112.3K | ★ 1.1M |
| Earning Date | 02-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.93 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | $29.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.94 | $4.02 |
| 52 Week High | $13.58 | $14.06 |
Technical Indicators
Market Signals| Indicator | ISOU | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 42.59 | 33.03 |
| Support Level | $9.72 | $7.66 |
| Resistance Level | $10.27 | $9.28 |
| Average True Range (ATR) | 0.73 | 0.32 |
| MACD | -0.14 | 0.05 |
| Stochastic Oscillator | 25.94 | 20.85 |
Price Performance
Historical ComparisonAbout ISOU IsoEnergy Ltd.
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Thorburn Lake, Radio, Geiger, and Larocque East. and others. It operates in Canada, the United States, and Australia.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.